Trinity Biotech (TRIB) Other Non-Current Assets (2009 - 2025)
Trinity Biotech (TRIB) posted quarterly Other Non-Current Assets of $28000.0 for Q4 2025, little changed year-on-year from $28000.0 in Q4 2024, and little changed on a QoQ basis from $28000.0 in Q2 2025.
Trinity Biotech (TRIB) Other Non-Current Assets (2009 - 2025) Analysis & Trends
Trinity Biotech (TRIB) has reported Other Non-Current Assets for 17 consecutive years, with $28000.0 the latest figure, recorded in Q4 2025.
- Quarterly Other Non-Current Assets changed 0.0% year-over-year to $28000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $28000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $28000.0, changed 0.0% from the prior year.
- Other Non-Current Assets was little changed at $28000.0 in Q4 2025 per TRIB's latest filing, from $28000.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for TRIB reached as high as $315000.0 in Q1 2021 and fell as low as $28000.0 in Q4 2024.
- A 5-year average of $133944.4 and a median of $114000.0 in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets slumped 64.56% — and 2025, when it changed 0.0%.
- Year by year, Other Non-Current Assets stood at $207000.0 in 2021, then plunged by 32.85% to $139000.0 in 2022, then slumped by 43.17% to $79000.0 in 2023, then sank by 64.56% to $28000.0 in 2024, then changed by 0.0% to $28000.0 in 2025.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $28000.0, $28000.0, and $28000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | 28,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 28,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | 43,000.00 |
| Jun 30, 2024 | 79,000.00 |
| Mar 31, 2024 | 79,000.00 |
| Dec 31, 2023 | 79,000.00 |
| Sep 30, 2023 | 98,000.00 |
| Jun 30, 2023 | 108,000.00 |
| Mar 31, 2023 | 120,000.00 |
| Dec 31, 2022 | 139,000.00 |
| Sep 30, 2022 | 155,000.00 |
| Jun 30, 2022 | 207,000.00 |
| Mar 31, 2022 | 175,000.00 |
| Dec 31, 2021 | 207,000.00 |
| Sep 30, 2021 | 244,000.00 |
| Jun 30, 2021 | 279,000.00 |
| Mar 31, 2021 | 315,000.00 |
| Dec 31, 2020 | 355,000.00 |
| Sep 30, 2020 | 387,000.00 |